Subscribe to Search results

Professor Blackburn wrote to Sir George Godber that directors felt an urgent need to increase supplies of Factor 8 concentrate because if British preparation could not be made available, commercial preparations should be bought.

Published on:

Dr Maycock wrote to Dr Reid that the UK should aim to be self-sufficient in the supply of preparations of anti-haemophilic globulin and Factor 9.

Published on:

Sir George Godber wrote to Sir Philip Rogers that due to increasing expenditure on commercial products being licenced there was a need to consider how far the home supply could be increased, leading to a lower cost.

Published on:

Sir George Godber wrote to Sir Philip Rogers that the expense of producing commercial or domestic concentrate was thought to be unavoidable in principle and providing domestic supplies would likely be cheaper than purchasing commercial concentrate.

Published on:

The initial aim was to supply concentrate made from 250,000 donations for use in home treatment, with the balance being cryoprecipitate.

Published on:

The supply of plasma for cryoprecipitate and for sending it to make concentrate at that stage was 300,000 donations a year.

Published on:

Dr John Wallace argued that the threshold required was that an adequate amount of a good quality cryoprecipitate would probably cover most clinical indications for Factor 8 therapy.

Published on:

In a meeting it was stressed that Dr Bigg's paper indicated in five years time there may be a need for more material, haemophilia centre directors and transfusion directors approved the contents of the paper and recommended that this document be used as the basis for planning the future requirements for Factor 8 in the United Kingdom.

Published on:

Dr Biggs argued that the problem pertained to large available stocks of therapeutic materials in stores because no-one would buy them whilst patients were simultaneously in dire need of this same material.

Published on:

In Lord David Owen's response to parliamentary questions he argued that concentrates were the optimum treatment and commercial product was available. However, UK domestic production should increase and home treatment was desirable.

Published on:

The main reason for the expansion in producing clotting factor concentrates at the time was to produce more immunoglobulin to prevent rubella in pregnancy, following an outbreak.

Published on:

Transfusion directors in the Joint Steering Committee on Blood Products Production increased the goal of 250,000 donations in March 1973 to 275,000 in June and July 1973.

Published on:

The goal of 275,000 donations for Factor 8 production had not been met a year after it had been given from 1973 to 1974.

Published on:

Dr Maycock argued for the principle of self-sufficiency and that unpaid donations must be preserved, blood transfusion services in the UK must be self-supporting and there should be agreed UK targets for the provision of preparations of human blood. The supply of plasma for fractionation needed to increase if the shortfall in meeting the anticipated demand was to be met from within the NHS.

Published on:

An article in The Lancet demonstrated the pressure put on the Government to act by clinicians, the medical press, NBTS and advisory bodies.

Published on:

Professor Blackburn wrote to Dr Waiter, which demonstrated the pressure put on the Government to act by clinicians, by the medical press, by NBTS and advisory bodies.

Published on:

A letter was written to Dr Waiter which demonstrated the pressure put on the Government to act by clinicians, the medical press, NBTS and advisory bodies.

Published on:

Dr Waiter wrote to Professor Blackburn, which demonstrated the pressure put on the Government to act by clinicians, the medical press, NBTS and advisory bodies.

Published on:

Lord David Owen stated that a major motivating factor for self-sufficiency, as far as he was concerned, was to ensure the safety of the patient. This included dangers of hepatitis, and the increased risks posed by the pool sizes used by commercial companies.

Published on:

A note of a meeting with the Minister of State (Health) outlined that the Haemophilia Society was anxious that the volume target set by the Department for self-sufficiency might not be sufficient in practice.

Published on: